Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance.

Pharmaceutics · 2023 · PMC10224401 · PMID 37242667

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Further analysis of the data in Table 2 revealed that formulations with the same BSA concentration and different drug concentrations showed a decreasing trend in entrapment efficiency values as follows, F6 > F4 > F7, F5 > F3 > F8, and F1 > F2 > F9.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.